inmunebio.jpg
INmune Bio Inc. Presents Preclinical Data at SITC 2023 Showing INB03 is an Innate Immune Check Point Inhibitor that Downregulates SIRPα
30 oct. 2023 09h07 HE | INmune Bio, Inc.
SIRP-CD47 is an innate immune checkpoint known as the “don’t eat me” signal. INB03 downregulates expression of SIRPα on macrophages promote increased cancer cell death by antibody dependent cellular...
Breast Health Educational Workshop
Whittier Street Health Center Awarded a Grant to Expand Breast Cancer Services as Part of President's Reignited Cancer Moonshot, the Biden-Harris Administration Awards
09 févr. 2023 18h00 HE | Whittier Street Health Center
BOSTON, Feb. 09, 2023 (GLOBE NEWSWIRE) -- A $500,000 grant was awarded to Whittier Street Health Center to expand its breast cancer screening program, in partnership with Dana-Farber Cancer...
QT Imaging
QT Imaging, Inc. Reaches New Milestones with Its Breakthrough Ultrasound Technology for Breast Imaging
24 janv. 2022 07h43 HE | US Capital Global
San Francisco, California, USA, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Last year, US Capital Global Securities LLC, an affiliate of US Capital Global, launched a convertible note offering of up to $30...
inmunebio.jpg
INmune Bio, Inc. Announces Key Breast Cancer Treatment Resistance Data to be Presented at the 2021 San Antonio Breast Cancer Symposium
09 déc. 2021 09h01 HE | INmune Bio, Inc.
Data suggests in triple negative breast cancer that MUC4 predicts survival and resistance to immunotherapy and that INB03 reverses resistance by decreasing immunosuppression in the TME Boca...